Corporate News     12-Sep-13
Vivimed allots equity shares
At an issue price of Rs 350
The board of directors of Vivimed Labs in its meeting held on 10 September 2013 has allotted 142,857 equity shares at an issue price of Rs 350 (i.e. face value of Rs 10 and a premium of Rs 340) to Dr Kumar Kurumaddali and Prashanthi Alamuru pursuant to the resolutions passed in the extra ordinary general meeting held on 12 March 2013.
Previous News
  Vivimed Labs reports consolidated net loss of Rs 27.46 crore in the March 2021 quarter
 ( Results - Announcements 29-Jun-21   08:08 )
  Vivimed Labs standalone net profit declines 21.47% in the June 2018 quarter
 ( Results - Announcements 14-Aug-18   12:42 )
  Vivimed Labs to discuss results
 ( Corporate News - 23-Aug-24   19:39 )
  Vivimed Labs to discuss results
 ( Corporate News - 03-Aug-21   13:19 )
  Vivimed Labs Ltd leads losers in 'B' group
 ( Hot Pursuit - 20-Jun-22   14:45 )
  Vivimed Labs consolidated net profit declines 17.17% in the September 2018 quarter
 ( Results - Announcements 16-Nov-18   17:00 )
  Vivimed Labs consolidated net profit declines 99.91% in the March 2019 quarter
 ( Results - Announcements 02-Jun-19   08:31 )
  Vivimed Labs to convene board meeting
 ( Corporate News - 06-Nov-20   13:27 )
  Vivimed Labs consolidated net profit rises 809.99% in the March 2017 quarter
 ( Results - Announcements 14-Jun-17   15:56 )
  Vivimed Labs reports standalone net loss of Rs 264.85 crore in the March 2023 quarter
 ( Results - Announcements 01-Jun-23   07:46 )
  Vivimed secures additional investment of USD 7.5 mn in its overseas subsidiary
 ( Corporate News - 01-Jan-18   09:52 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top